Drug intelligence / Profile preview

pseudotropine

Development stage
Unknown
Modality
Small Molecules
01

Overview

Pseudotropine is a naturally occurring tropane alkaloid and an isomer of tropine. It is found in certain plants such as Atropa belladonna and Erythroxylum coca. Pseudotropine is produced via the NADPH-dependent reduction of the 3-carbonyl group of tropinone to a beta-hydroxyl group by the enzyme tropinone reductase-II[4][3]. It serves as a biosynthetic intermediate in the formation of other medicinally important alkaloids like hyoscyamine (atropine) and cocaine[4][3]. Pseudotropine itself has been used primarily as a research chemical and synthetic building block for drug discovery targeting various therapeutically interesting targets including novel nicotinic receptor agonists[1][9]. There are no approved medical indications or clinical uses for pseudotropine; it remains an experimental compound.

Other names
3β-tropanolψ-tropine3-pseudotropanolexo-8-methyl-8-azabicyclo[3.2.1]octan-3-olpseudotropanol(1αH,5αH)-tropan-3β-ol
02

Targets

TR-II (Tropinone reductase II)mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on pseudotropine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pseudotropine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call